Non-severe group (n = 293) | Severe group (n = 35) | P value | |
---|---|---|---|
Age (y) | 56.0 (49.0–66.0) | 62.0 (45.0–66.0) | 0.327 |
Gender (n) | 0.616 | ||
Male | 197 (67.24) | 25 (71.43) | |
Female | 96 (32.76) | 10 (28.57) | |
Diabetes mellitus (n) | 131 (44.71) | 22 (62.86) | 0.042 |
BMI (kg/m2) | 24.12 ± 3.14 | 22.94 ± 2.76 | 0.170 |
Maximal body temperature (℃) | 39.2 (38.6–40.0) | 39.4 (39.0–40.0) | 0.041 |
Serum lipid | |||
TC (mmol/L) | 2.90 (2.41–3.64) | 1.83 (1.58–2.42) | < 0.001 |
HDL-C (mmol/L) | 0.59 (0.45–0.73) | 0.36 (0.24–0.45) | < 0.001 |
LDL-C (mmol/L) | 1.92 (1.55–2.38) | 1.22 (0.97–1.50) | < 0.001 |
TG (mmol/L) | 1.05 (0.83–1.43) | 1.40 (1.00–2.22) | 0.003 |
Lp(a) (mg/L) | 115.0 (56.5–239.5) | 23.0 (12.0–67.0) | < 0.001 |
Hepatic function | |||
Albumin (g/L) | 29.79 ± 4.86 | 28.07 ± 5.37 | 0.051 |
TBIL (μmol/L) | 11.80 (8.45–18.15) | 27.70 (12.0–53.60) | < 0.001 |
DBIL (μmol/L) | 5.90 (3.90–10.10) | 13.80 (7.50–41.70) | < 0.001 |
ALT (U/L) | 46.70 (26.15–69.85) | 78.30 (38.80–253.40) | < 0.001 |
AST (U/L) | 35.60 (23.65–52.85) | 83.50 (35.60–276.60) | < 0.001 |
ALP (U/L) | 174.0 (119.6–259.0) | 168.2 (109.1–256.0) | 0.841 |
LDH (U/L) | 250.0(207.5–321.0) | 333.0 (280.0–426.0) | < 0.001 |
Blood routine | |||
WBC (109/L) | 10.60 (8.18–13.50) | 14.20 (9.57–23.80) | 0.001 |
NE% (%) | 82.55 (76.19–87.00) | 89.80 (85.30–91.50) | < 0.001 |
HGB (g/L) | 113.50 ± 17.83 | 99.80 ± 17.49 | < 0.001 |
PLT (109/L) | 224.0 (145.0–319.0) | 65.0 (34.0–177.0) | < 0.001 |
Coagulation function | |||
PT (s) | 13.60 (12.85–14.40) | 15.80 (13.90–21.50) | < 0.001 |
APTT (s) | 29.90 (27.65–32.70) | 38.00 (33.20–44.00) | < 0.001 |
FIB (g/L) | 6.06 (4.75–6.95) | 4.46 (2.44–6.44) | < 0.001 |